Given the downregulated expression of PTPN18 in triple-negative breast cancer cells, it can also be inferred that the degradation of ETS1 regulated by PTPN18 may be one of the reasons that ETS1 is only expressed in triple-negative breast cancer cells. This evidence concerns the gene PTPN18 and triple-negative breast carcinoma.